The world has waited decades for a malaria vaccine, and now two have come along in quick succession. On October 2, the World Health Organization (WHO) recommended that a new malaria vaccine, R21, developed by the University of Oxford be rolled out for the prevention of malaria in children, just two years after another vaccine, the RTS,S, got its endorsement.
In this episode of The Conversation Weekly podcast, we find out why it’s been so hard to find a malaria vaccine – and hear from the scientists behind the new breakthrough.
Read the full article on The Conversation website, featuring: Adrian Hill Director of the Jenner Institute, University of Oxford; Alassane Dicko Professor of Epidemiology and Public Health, Malaria Research and Training Center, Université des sciences, des techniques et des technologies de Bamako and Faith Osier Co-Director, Institute of Infection, Chair, Immunology & Vaccinology, Imperial College London
Oxford is a subscribing member of The Conversation. Find out how you can write for The Conversation.